An ACHF partnership with Pfizer, Inc.
Disease prevention is a priority in our nation and is a key focus of CDC’s targeted demographic (young adults 16 through 23 years old) for encouraging vaccines in our nation; however, meaningful data on campus vaccine coverage among students are incomplete and there is a need for enhanced reporting on vaccine administration rates, completion rates, and surveillance.
ACHF and Pfizer, Inc., have partnered to develop a knowledge base for the current state of vaccine coverage and aid in the development of thoughtful, rigorous, and feasible vaccination policies to help protect U.S. college students from vaccine-preventable diseases.
Project Outputs
These reports help practitioners and policymakers understand how pre-matriculation vaccine requirements influence actual coverage rates and ways to improve vaccine readiness on campus.
Topic
COVID-19, Immunizations, Infectious Diseases, Public Health, Research & Survey Data
Increasing Campus Vaccine Coverage on High-Needs Campuses
This project provides grant funding to support the development of new programs, practices, and strategies aimed at increasing vaccine coverage on college campuses.
Supporting STI Prevention & Testing on High-Needs Campuses
The STI Prevention and Testing Mini Grant Program supports high-needs campuses in developing innovative, sustainable strategies for STI education, prevention, and testing.
Assessing HBCU Student Health & Wellness
With support from ACHF, the HBCU Health Equity Data Consortium (HEDC) will…